Device News
VisionCare's Macular Degeneration Telescope Implant Named 'Best of What's New' 2010 by Popular Science PRNewswire
View ArticleNews
Regeneron Schedules November 22, 2010 Teleconference and Webcast to Discuss Results of Two Phase 3 Studies with VEGF Trap-Eye in Wet Age-related Macular Degeneration Yahoo/PR NewsWire
View ArticleRegeneron Pharmaceuticals Shares Plunged: What You Need to Know
Regeneron Pharmaceuticals Shares Plunged: What You Need to Know Motley Fool
View ArticleGenentech, Once Known For Innovation, Is Pursuing A Nexium Strategy With...
Genentech, Once Known For Innovation, Is Pursuing A Nexium Strategy With Lucentis Forbes
View ArticleRegeneron: A Poke in the Eye From the FDA
Regeneron: A Poke in the Eye From the FDA Motley Fool
View ArticleStem-Cell Clinical Trials Move Debate Beyond Labs
Stem-Cell Clinical Trials Move Debate Beyond Labs WSJ Online
View ArticleRegeneron Announces FDA Approval of EYLEA™ (aflibercept) Injection for the...
Regeneron Announces FDA Approval of EYLEA™ (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration Yahoo/PR NewsWire
View ArticleStem Cell Treatment for Eye Diseases Shows Promise
Stem Cell Treatment for Eye Diseases Shows Promise NY Times, NY
View ArticleSeeing Black Gives Regeneron a 9% Pop
Seeing Black Gives Regeneron a 9% Pop Motley Fool
View ArticleAvastin, Lucentis equally effective at improving vision, big study finds
Avastin, Lucentis equally effective at improving vision, big study finds Fierce Pharma
View ArticleOhr Pharmaceutical Given “Strong-Buy” Rating at Vista Partners (OHRP)
Ohr Pharmaceutical Given “Strong-Buy” Rating at Vista Partners (OHRP) Zolmax
View ArticleNew Developments In Lipids To Watch Closely
New Developments In Lipids To Watch Closely Seeking Alpha
View ArticleAlimera Sciences shares fall on UK price setback
Alimera Sciences shares fall on UK price setback Yahoo/AP
View Article10 Drugs Approved by the FDA in 2012 to Be Thankful For
10 Drugs Approved by the FDA in 2012 to Be Thankful For Motley Fool
View ArticleRegeneron Pharma raises sales forecast for Eylea
Regeneron Pharma raises sales forecast for Eylea Yahoo/AP
View ArticlePhase II Calamity Dooms Ohr's Eye Drops
Phase II Calamity Dooms Ohr's Eye Drops Seeking Alpha
View Article
